“Curative Conversion of Metastatic Gastric Cancer After Pembrolizumab-Trastuzumab-Based Therapy in a PD-L1-Negative, HER2-Positive Patient: A Case Report and Literature Review” (2026) MENA Journal of Case Reports, 1(1), pp. 30–38. doi:10.64913/mmrmjcr.v1i1.21.